Article

Thyroid Cancer Following Breast Cancer in CHEK2 Carriers: Surveillance, Treatment or Genetic Susceptibility?

2026-07-05

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Several studies report an increased incidence of thyroid cancer following a diagnosis of breast cancer. Possible explanations include increased medical surveillance, carcinogenic effects of treatment of breast cancer patients and shared genetic susceptibility. <bold>Methods</bold> We present an illustrative family in which two women with a germline splicing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b98b4b10-348e-5bee-a14f-2dac809549cc
DOI: 10.21203/rs.3.rs-9987221/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thyroid Cancer Following Breast Cancer in CHEK2 Carriers: Surveillance, Treatment or Genetic Susceptibility?DOI 10.21203/rs.3.rs-9987221/v1Read

Risk of Second Primary Thyroid Cancer in Women with Breast CancerSemantic proximity Read

CHEK2 mutations and the risk of papillary thyroid cancer.Semantic proximity Read

The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry.Semantic proximity Read

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.Semantic proximity Read

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial studySemantic proximity Read

CHEK2-related breast cancer: real-world challenges.Semantic proximity Read

CHEK2 Founder Variants and Thyroid Cancer Risk.Semantic proximity Read

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalSemantic proximity Read

Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?Semantic proximity Read

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.Semantic proximity Read

Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.Semantic proximity Read

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerSemantic proximity Read